Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel B Walter

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
Pediatrics|August 26, 2016
Rotavirus Vaccine and Intussusception HospitalizationsEmmanuel B Walter, Mary Allen Staat
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Improving Influenza Prevention: Modest Changes With Large EffectsEmmanuel B Walter, Robert L Atmar
Annual Review of Medicine|December 10, 2024
New Approaches to Respiratory Syncytial Virus Prevention and TreatmentEmmanuel B Walter, Flor M Munoz
North Carolina Medical Journal|March 2, 2021
Vaccine Development: Steps to Approval of an Investigational VaccineEmmanuel B Walter, M Anthony Moody
North Carolina Medical Journal|March 28, 2013
Immunizations for preteensEmmanuel B Walter, Richard J Chung
Pediatrics|July 4, 2013
Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses?Emmanuel B Walter, Dennis A Clements
Current Opinion in Pediatrics|March 2, 2022
Prevention of pneumococcal infections in childhood: two decades of progressEmmanuel B Walter, Michael J Smith
Human Vaccines & Immunotherapeutics|June 2, 2016
Effect of antipyretic analgesics on immune responses to vaccinationEzzeldin Saleh, M Anthony Moody, Emmanuel B Walter
The New England Journal of Medicine|March 2, 2022
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. ReplyEmmanuel B Walter, Kawsar R Talaat, Alejandra Gurtman
The New England Journal of Medicine|January 19, 2022
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. ReplyEmmanuel B Walter, Kawsar R Talaat, Alejandra Gurtman
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Pediatrics|August 26, 2016
Rotavirus Vaccine and Intussusception HospitalizationsEmmanuel B Walter, Mary Allen Staat
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Improving Influenza Prevention: Modest Changes With Large EffectsEmmanuel B Walter, Robert L Atmar
Annual Review of Medicine|December 10, 2024
New Approaches to Respiratory Syncytial Virus Prevention and TreatmentEmmanuel B Walter, Flor M Munoz
North Carolina Medical Journal|March 2, 2021
Vaccine Development: Steps to Approval of an Investigational VaccineEmmanuel B Walter, M Anthony Moody
North Carolina Medical Journal|March 28, 2013
Immunizations for preteensEmmanuel B Walter, Richard J Chung
Pediatrics|July 4, 2013
Pneumococcal conjugate vaccine: are 3 doses equal to 4 doses?Emmanuel B Walter, Dennis A Clements
Current Opinion in Pediatrics|March 2, 2022
Prevention of pneumococcal infections in childhood: two decades of progressEmmanuel B Walter, Michael J Smith
Human Vaccines & Immunotherapeutics|June 2, 2016
Effect of antipyretic analgesics on immune responses to vaccinationEzzeldin Saleh, M Anthony Moody, Emmanuel B Walter
The New England Journal of Medicine|March 2, 2022
More on BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. ReplyEmmanuel B Walter, Kawsar R Talaat, Alejandra Gurtman
The New England Journal of Medicine|January 19, 2022
BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. ReplyEmmanuel B Walter, Kawsar R Talaat, Alejandra Gurtman
Pageof 14